Nonalcoholic Fatty Liver Disease and Hyperuricemia: A Close Relation with Hepatic Insulin Resistance after Nicotinic Acid Treatment?

E. Blond; J. Goudable; M. Laville

doi:10.1055/s-0034-1390463

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2015; 47(07): 546-547
DOI: 10.1055/s-0034-1390463

Reply to Letter to the Editor

Nonalcoholic Fatty Liver Disease and Hyperuricemia: A Close Relation with Hepatic Insulin Resistance after Nicotinic Acid Treatment?

E. Blond

¹Research Centre in Human Nutrition Rhône-Alpes and CENS (Centre of European Nutrition Safety and health), Hospices Civils de Lyon, Pierre Bénite, France

²INSERM U1060, CarMeN Laboratory, Lyon 1 University, INRA 1235, Oullins, France

,

J. Goudable

¹Research Centre in Human Nutrition Rhône-Alpes and CENS (Centre of European Nutrition Safety and health), Hospices Civils de Lyon, Pierre Bénite, France

²INSERM U1060, CarMeN Laboratory, Lyon 1 University, INRA 1235, Oullins, France

,

M. Laville

¹Research Centre in Human Nutrition Rhône-Alpes and CENS (Centre of European Nutrition Safety and health), Hospices Civils de Lyon, Pierre Bénite, France

²INSERM U1060, CarMeN Laboratory, Lyon 1 University, INRA 1235, Oullins, France

› Author Affiliations

Abstract

Full Text

References

References
1 Sazonov V, Maccubbin D, Sisk CM, Canner PL. Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose. Int J Clin Pract 2013; 67: 297-302
2 Ong KL, Barter PJ, Waters DD. Cardiovascular drugs that increase the risk of new-onset diabetes. Am Heart J 2014; 167: 421-428
3 Zafrir B, Jain M. Lipid-lowering Therapies, Glucose Control and Incident Diabetes: Evidence, Mechanisms and Clinical Implications. Cardiovasc Drugs Ther 2014; 28: 361-377
4 Blond E, Rieusset J, Alligier M, Lambert-Porcheron S, Bendridi N, Gabert L, Chetiveaux M, Debard C, Chauvin MA, Normand S, Roth H, de Gouville AC, Krempf M, Vidal H, Goudable J, Laville M. “Niacin” Study Group . Nicotinic acid effects on insulin sensitivity and hepatic lipid metabolism: an in vivo to in vitro study. Horm Metab Res 2014; 46: 390-396
5 Katiski N, Athyros VG, Karagiannis A, Mikhailidis DP. Nicotinic acid and New Onset Diabetes. Horm Metab Res 2015; 47: 544-545
6 Kei A, Elisaf MS. Nicotinic acid: clinical considerations. Expert Opin Drug Saf 2012; 11: 551-564
7 Fabbrini E, Mohammed BS, Korenblat KM, Magkos F, McCrea J, Patterson BW, Klein S. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2010; 95: 2727-2735
8 Ganji SH, Kukes GD, Lambrecht N, Kashyap ML, Kamanna VS. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 2014; 306: G320-G327
9 Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?. Metabolism 2006; 55: 1293-1301
10 Sertoglu E, Ercin CN, Celebi G, Gurel H, Kayadibi H, Genc H, Kara M, Dogru T. The relationship of serum uric acid with non-alcoholic fatty liver disease. Clin Biochem 2014; 47: 383-388
11 Lee JW, Cho YK, Ryan M, Kim H, Lee SW, Chang E, Joo KJ, Kim JT, Kim BS, Sung KC. Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver 2010; 4: 378-383
12 Nakamura K, Sakurai M, Miura K, Morikawa Y, Nagasawa SY, Ishizaki M, Kido T, Naruse Y, Nakashima M, Nogawa K, Suwazono Y, Nakagawa H. HOMA-IR and the risk of hyperuricemia: A prospective study in non-diabetic Japanese men. Diabetes Res Clin Pract 2014; 106: 154-160
13 Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol 2012; 176: 108-116
14 Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, Ishimoto T, Sautin YY, Lanaspa MA. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 2013; 62: 3307-3315
15 Perry RJ, Samuel VT, Petersen KF, Shulman GI. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 2014; 510: 84-91
16 Zhu Y, Hu Y, Huang T, Zhang Y, Li Z, Luo C, Luo Y, Yuan H, Hisatome I, Yamamoto T, Cheng J. High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochem Biophys Res Commun 2014; 447: 707-714